K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis

Por Wang, Suizhao, Wang, Shu, Maeng, Hoyoung, Young, Daniel P., Prakash, Om, Fayad, Luis E., Younes, Anas, Samaniego, Felipe
Publicado em 2007

HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma

Por Jones, Richard J., Baladandayuthapani, Veerabhadran, Neelapu, Sattva, Fayad, Luis E., Romaguera, Jorge E., Wang, Michael, Sharma, Rakesh, Yang, Dajun, Orlowski, Robert Z.
Publicado em 2011

Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma

Por Fowler, Nathan H., Nastoupil, Loretta J., Hagemeister, Frederick B., Neelapu, Sattva S., Fayad, Luis E., LeBlanc, Denise, Samaniego, Felipe, Cheah, Chan Yoon
Publicado no Haematologica (2015)

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease

Por van Rhee, Frits, Casper, Corey, Voorhees, Peter M., Fayad, Luis E., van de Velde, Helgi, Vermeulen, Jessica, Qin, Xiang, Qi, Ming, Tromp, Brenda, Kurzrock, Razelle
Publicado no Oncotarget (2015)

Clinical Implications of PET-Negative Residual CT Masses after Chemotherapy for Diffuse Large B-Cell Lymphoma

Por Dabaja, Bouthaina S., Phan, Jack, Mawlawi, Osama, Medeiros, L. Jeffrey, Etzel, Carol, Liang, Fu-Wen, Podoloff, Donald, Oki, Yasuhiro, Hagemeister, Fredrick B., Chuang, Hubert, Fayad, Luis E., Westin, Jason Robert, Shihadeh, Ferial, Allen, Pamela K., Wogan, Christine F., Rodriguez, Alma
Publicado em 2013

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

Por Westin, Jason R., Thompson, Michael A., Cataldo, Vince D., Fayad, Luis E., Fowler, Nathan, Fanale, Michelle A., Neelapu, Saatva, Samaniego, Felipe, Romaguera, Jorge, Shah, Jatin, McLaughlin, Peter, Pro, Barbara, Kwak, Larry W., Sanjorjo, Perpetua, Murphy, William A., Jimenez, Camillo, Toth, Bela, Dong, Wenli, Hagemeister, Fredrick B.
Publicado em 2012

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

Por Younes, Anas, Oki, Yasuhiro, McLaughlin, Peter, Copeland, Amanda R., Goy, Andre, Pro, Barbara, Feng, Lei, Yuan, Ying, Chuang, Hubert H., Macapinlac, Homer A., Hagemeister, Fredrick, Romaguera, Jorge, Samaniego, Felipe, Fanale, Michelle A., Dabaja, Bouthaina Shbib, Rodriguez, Maria A., Dang, Nam, Kwak, Larry W., Neelapu, Sattva S., Fayad, Luis E.
Publicado em 2012

Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: An open label single arm...

Por Oki, Yasuhiro, Ewer, Michael S., Lenihan, Daniel J., Fisch, Michael J., Hagemeister, Fredrick B., Fanale, Michelle, Romaguera, Jorge, Pro, Barbara, Fowler, Nathan, Younes, Anas, Astrow, Alan B., Huang, Xuelin, Kwak, Larry W., Samaniego, Felipe, McLaughlin, Peter, Neelapu, Sattva S., Wang, Michael, Fayad, Luis E., Durand, Jean-Bernard, Rodriguez, M. Alma
Publicado no Clin Lymphoma Myeloma Leuk (2014)

Safety and Activity of PD1 Blockade by Pidilizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: a Single Group, Open-label, Phase 2 Trial

Por Westin, Jason R., Chu, Fuliang, Zhang, Min, Fayad, Luis E., Kwak, Larry W., Fowler, Nathan, Romaguera, Jorge, Hagemeister, Fredrick, Fanale, Michelle, Samaniego, Felipe, Feng, Lei, Baladandayuthapani, Veerabhadran, Wang, Zhiqiang, Ma, Wencai, Gao, Yanli, Wallace, Michael, Vence, Luis M., Radvanyi, Laszlo, Muzzafar, Tariq, Rotem-Yehudar, Rinat, Davis, R. Eric, Neelapu, Sattva S.
Publicado em 2013

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20(+) Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

Por Sehn, Laurie H., Goy, Andre, Offner, Fritz C., Martinelli, Giovanni, Caballero, M. Dolores, Gadeberg, Ole, Baetz, Tara, Zelenetz, Andrew D., Gaidano, Gianluca, Fayad, Luis E., Buckstein, Rena, Friedberg, Jonathan W., Crump, Michael, Jaksic, Branimir, Zinzani, Pier Luigi, Padmanabhan Iyer, Swaminathan, Sahin, Deniz, Chai, Akiko, Fingerle-Rowson, Günter, Press, Oliver W.
Publicado no J Clin Oncol (2015)

Safety, activity, and immune effects of lenalidomide and rituximab in untreated indolent lymphoma

Por Fowler, Nathan H, Davis, R Eric, Rawal, Seema, Nastoupil, Loretta, Hagemeister, Fredrick B, McLaughlin, Peter, Kwak, Larry W, Romaguera, Jorge E, Fanale, Michelle A, Fayad, Luis E, Westin, Jason R, Shah, Jatin, Orlowski, Robert Z, Wang, Michael, Turturro, Francesco, Oki, Yasuhiro, Claret, Linda C, Feng, Lei, Baladandayuthapani, Veerabhadran, Muzzafar, Tariq, Tsai, Kenneth Y, Samaniego, Felipe, Neelapu, Sattva S
Publicado no Lancet Oncol (2014)

Non-Hodgkin’s Lymphomas, Version 4.2014: Clinical Practice Guidelines in Oncology

Por Zelenetz, Andrew D., Gordon, Leo I., Wierda, William G., Abramson, Jeremy S., Advani, Ranjana H., Andreadis, C. Babis, Bartlett, Nancy, Byrd, John C., Czuczman, Myron S., Fayad, Luis E., Fisher, Richard I., Glenn, Martha J., Harris, Nancy Lee, Hoppe, Richard T., Horwitz, Steven M., Kelsey, Christopher R., Kim, Youn H., Krivacic, Susan, LaCasce, Ann S., Nademanee, Auayporn, Porcu, Pierluigi, Press, Oliver, Rabinovitch, Rachel, Reddy, Nishitha, Reid, Erin, Saad, Ayman A., Sokol, Lubomir, Swinnen, Lode J., Tsien, Christina, Vose, Julie M., Yahalom, Joachim, Zafar, Nadeem, Dwyer, Mary, Sundar, Hema
Publicado no J Natl Compr Canc Netw (2014)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015: Clinical Practice Guidelines in Oncology

Por Zelenetz, Andrew D., Gordon, Leo I., Wierda, William G., Abramson, Jeremy S., Advani, Ranjana H., Andreadis, C. Babis, Bartlett, Nancy, Byrd, John C., Czuczman, Myron S., Fayad, Luis E., Fisher, Richard I., Glenn, Martha J., Habermann, Thomas M., Harris, Nancy Lee, Hoppe, Richard T., Horwitz, Steven M., Kelsey, Christopher R., Kim, Youn H., Krivacic, Susan, LaCasce, Ann S., Nademanee, Auayporn, Porcu, Pierluigi, Press, Oliver, Rabinovitch, Rachel, Reddy, Nishitha, Reid, Erin, Saad, Ayman A., Sokol, Lubomir, Swinnen, Lode J., Tsien, Christina, Vose, Julie M., Wilson, Lynn, Yahalom, Joachim, Zafar, Nadeem, Dwyer, Mary, Sundar, Hema
Publicado no J Natl Compr Canc Netw (2015)

Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients

Por Miranda, Roberto N., Aladily, Tariq N., Prince, H. Miles, Kanagal-Shamanna, Rashmi, de Jong, Daphne, Fayad, Luis E., Amin, Mitual B., Haideri, Nisreen, Bhagat, Govind, Brooks, Glen S., Shifrin, David A., O'Malley, Dennis P., Cheah, Chan Y., Bacchi, Carlos E., Gualco, Gabriela, Li, Shiyong, Keech, John A., Hochberg, Ephram P., Carty, Matthew J., Hanson, Summer E., Mustafa, Eid, Sanchez, Steven, Manning, John T., Xu-Monette, Zijun Y., Miranda, Alonso R., Fox, Patricia, Bassett, Roland L., Castillo, Jorge J., Beltran, Brady E., de Boer, Jan Paul, Chakhachiro, Zaher, Ye, Dongjiu, Clark, Douglas, Young, Ken H., Medeiros, L. Jeffrey
Publicado em 2014